Thorne Healthtech, Inc. Common Stock
THRN
THRN was delisted on the 13th of October, 2023.
44 hedge funds and large institutions have $26.2M invested in Thorne Healthtech, Inc. Common Stock in 2022 Q3 according to their latest regulatory filings, with 4 funds opening new positions, 16 increasing their positions, 18 reducing their positions, and 9 closing their positions.
2% less capital invested
Capital invested by funds: $26.7M → $26.2M (-$462K)
10% less funds holding
Funds holding: 49 → 44 (-5)
11% less repeat investments, than reductions
Existing positions increased: 16 | Existing positions reduced: 18
56% less first-time investments, than exits
New positions opened: 4 | Existing positions closed: 9
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
+$1.56M |
| 2 |
Geode Capital Management
Boston,
Massachusetts
|
+$155K |
| 3 |
BlackRock
New York
|
+$148K |
| 4 |
SG Americas Securities
New York
|
+$51.7K |
| 5 |
HSBC Holdings
London,
United Kingdom
|
+$45.1K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
-$336K |
| 2 |
MA
MYDA Advisors
Woodmere,
New York
|
-$334K |
| 3 |
EMFAT
Emerald Mutual Fund Advisers Trust
Leola,
Pennsylvania
|
-$191K |
| 4 |
Renaissance Technologies
New York
|
-$173K |
| 5 |
DCM
Driehaus Capital Management
Chicago,
Illinois
|
-$131K |
THRN Hedge Fund Activity: Q3 2022 in Review
44 of the 5,806 institutional investors tracked by Wall St. Rank reported a position in Thorne Healthtech, Inc. Common Stock (THRN) for Q3 2022, worth a combined $26.2M — down 1.7% from $26.7M a quarter earlier.
Sellers outnumbered buyers: 9 funds closed out of THRN and 4 opened new positions — a net loss of 5 holders — while 18 trimmed existing stakes and 16 added.
The largest buyer was Vanguard Group, adding an estimated $1.56M. The largest seller was Millennium Management, exiting entirely with an estimated $336K sold.
- 44 institutional investors held Thorne Healthtech, Inc. Common Stock (THRN) as of Q3 2022, down from 49 in Q2 2022.
- Funds reported $26.2M of Thorne Healthtech, Inc. Common Stock stock for Q3 2022, down 1.7% quarter-over-quarter.
- 4 funds opened new Thorne Healthtech, Inc. Common Stock positions in Q3 2022 and 9 closed out, a net change of -5 holders.
- The largest Thorne Healthtech, Inc. Common Stock buyer in Q3 2022 was Vanguard Group, an estimated $1.56M added.
- The largest Thorne Healthtech, Inc. Common Stock seller in Q3 2022 was Millennium Management, an estimated $336K sold.
Based on aggregated 13F filings for Q3 2022.